Your browser doesn't support javascript.
loading
THE TOP-IMPLART PROTON LINEAR ACCELERATOR: INTERIM CHARACTERISTICS OF THE 35 MEV BEAM.
De Angelis, C; Ampollini, A; Bazzano, G; Della Monaca, S; Ghio, F; Giuliani, F; Lucentini, M; Montereali, R M; Nenzi, P; Notaro, C; Placido, C; Piccinini, M; Ronsivalle, C; Santavenere, F; Soriani, A; Spurio, A; Strigari, L; Surrenti, V; Trinca, E; Vadrucci, M; Cisbani, E; Picardi, L.
Affiliation
  • De Angelis C; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy.
  • Ampollini A; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Bazzano G; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Della Monaca S; Core Facilities, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, Italy.
  • Ghio F; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Giuliani F; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Lucentini M; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Montereali RM; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Nenzi P; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Notaro C; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Placido C; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Piccinini M; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Ronsivalle C; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Santavenere F; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Soriani A; Laboratory of Medical Physics, IRCCS - Regina Elena National Cancer Institute, Via E. Chianesi 53, Rome, Italy.
  • Spurio A; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
  • Strigari L; Laboratory of Medical Physics, IRCCS - Regina Elena National Cancer Institute, Via E. Chianesi 53, Rome, Italy.
  • Surrenti V; Department of Medical Physics, S. Orsola Malpighi University Hospital, Via Massarenti 9, Bologna, Italy.
  • Trinca E; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Vadrucci M; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Cisbani E; Department of Fusion and Nuclear Security, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), Via E. Fermi 45, Frascati Rome, Italy.
  • Picardi L; National Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità Viale Regina Elena 299, Rome, Italy.
Radiat Prot Dosimetry ; 186(1): 113-118, 2019 Dec 31.
Article in En | MEDLINE | ID: mdl-31141142
ABSTRACT
In the framework of the Italian TOP-IMPLART project (Regione Lazio), ENEA-Frascati, ISS and IFO are developing and constructing the first proton linear accelerator based on an actively scanned beam for tumor radiotherapy with final energy of 150 MeV. An important feature of this accelerator is modularity an exploitable beam can be delivered at any stage of its construction, which allows for immediate characterization and virtually continuous improvement of its performance. Currently, a sequence of 3 GHz accelerating modules combined with a commercial injector operating at 425 MHz delivers protons up to 35 MeV. Several dosimetry systems were used to obtain preliminary characteristics of the 35-MeV beam in terms of stability and homogeneity. Short-term stability and homogeneity better than 3% and 2.6%, respectively, were demonstrated; for stability an improvement with respect to the respective value obtained for the previous 27 MeV beam.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Particle Accelerators / Protons / Radiometry Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Particle Accelerators / Protons / Radiometry Language: En Year: 2019 Type: Article